TY - CHAP
T1 - Normobaric and Hyperbaric Oxygen Therapy for Ischemic Stroke and Other Neurological Conditions
AU - Moskowitz, Ari
AU - Yvonne Chan, Yu Feng
AU - Singhal, Aneesh B.
N1 - Copyright:
Copyright 2014 Elsevier B.V., All rights reserved.
PY - 2011/7/4
Y1 - 2011/7/4
KW - Centers for Disease Control (CDC) estimates - cerebrovascular diseases, cause of death in the United States
KW - HBO use in deep-sea divers - decompression sickness ("the bends") and arterial gas embolism
KW - Hyperbaric oxygen therapy - and HBO use in organ ischemia
KW - Hyperoxia, reducing cyclooxygenase-2 (COX-2) mRNA and MMP-9 - and intercellular adhesion molecule-1 (ICAM-1) levels
KW - NBO therapy, accessible - costing less, pleasant for patients, than the HBO
KW - Normobaric and hyperbaric oxygen therapy - ischemic stroke, other neurological conditions
KW - Normobaric oxygen therapy - 100% oxygen at atmospheric pressure, via face mask
KW - Oxygen therapy in acute ischemic stroke (AIS) - hyperoxia in cerebral ischemia
KW - Preclinical testing, and therapeutic time window, dosage - in stroke subtypes
UR - http://www.scopus.com/inward/record.url?scp=84885724178&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84885724178&partnerID=8YFLogxK
U2 - 10.1002/9781119975427.ch11
DO - 10.1002/9781119975427.ch11
M3 - Chapter
AN - SCOPUS:84885724178
SN - 9780470686683
SP - 159
EP - 177
BT - Chemistry and Biochemistry of Oxygen Therapeutics
PB - John Wiley and Sons
ER -